In vivo findings from syngeneic models of metastasis indicate that GPVI promotes metastasis in melanoma and lung cancer, and inhibition of GPVI offers a completely new therapeutic approach with minimal bleeding [24, 25]. This evidence concerns the gene GP6 and melanoma.